Moreover, berberine and pioglitazone have similar binding affinity to peroxisome proliferator-activated receptor gamma (PPARγ) protein, have an overlapping effect on Alzheimer’s disease (Wong et al., 2021). The gene discussed is PPARG; the disease is early-onset autosomal dominant Alzheimer disease.